Rudolf M C J, Logan S
Community Paediatrics, East Leeds Primary Care Trust and University of Leeds, Leeds, UK.
Arch Dis Child. 2005 Sep;90(9):925-31. doi: 10.1136/adc.2004.050179. Epub 2005 May 12.
To ascertain the long term outcomes in children diagnosed as having failure to thrive (FTT).
Systematic review of cohort studies. Medline, Psychinfo, Embase, Cinahl, Web of Science, Cochrane, and DARE databases were searched for potentially relevant studies.
cohort studies or randomised controlled trials in children <2 years old with failure to thrive defined as weight <10th centile or lower centile and/or weight velocity <10th centile, with growth, development, or behaviour measured at 3 years of age or older.
Thirteen studies met the inclusion criteria; eight included a comparison group, of which five included children identified in community settings. Two were randomised controlled trials. Attrition rates were 10-30%. Data from population based studies with comparison groups and which reported comparable outcomes in an appropriate form were pooled in a random effects meta-analysis. Four studies report IQ scores at follow up and the pooled standardised mean difference was -0.22 (95% CI -0.41 to -0.03). Two studies reported growth data as standard deviation scores. Their pooled weighted mean difference for weight was -1.24 SDS (95% CI -2.00 to -0.48), and for height -0.87 SDS (95% CI -1.47 to -0.28). No studies corrected for parental height, but two reported that parents of index children were shorter.
The IQ difference (equivalent to approximately 3 IQ points) is of questionable clinical significance. The height and weight differences are larger, but few children were below the 3rd centile at follow up. It is unclear to what extent observed differences reflect causal relations or confounding due to other variables. In the light of these results the aggressive approach to identification and management of failure to thrive needs reassessing.
确定被诊断为生长发育迟缓(FTT)的儿童的长期预后。
对队列研究进行系统评价。检索了Medline、Psychinfo、Embase、Cinahl、Web of Science、Cochrane和DARE数据库以查找潜在的相关研究。
针对2岁以下生长发育迟缓儿童的队列研究或随机对照试验,生长发育迟缓定义为体重低于第10百分位数或更低百分位数和/或体重增长速度低于第10百分位数,在3岁及以上测量生长、发育或行为。
13项研究符合纳入标准;8项研究包括一个对照组,其中5项研究纳入了在社区环境中识别出的儿童。2项为随机对照试验。失访率为10% - 30%。将来自有对照组的基于人群的研究且以适当形式报告了可比结果的数据纳入随机效应荟萃分析。4项研究报告了随访时的智商分数,汇总标准化均数差为 -0.22(95%可信区间 -0.41至 -0.03)。2项研究将生长数据报告为标准差分数。其体重汇总加权均数差为 -1.24 SDS(95%可信区间 -2.00至 -0.48),身高为 -0.87 SDS(95%可信区间 -1.47至 -0.28)。没有研究对父母身高进行校正,但有2项研究报告指数儿童的父母较矮。
智商差异(相当于约3个智商点)的临床意义存疑。身高和体重差异更大,但随访时很少有儿童低于第3百分位数。尚不清楚观察到的差异在多大程度上反映因果关系或其他变量导致的混杂。鉴于这些结果,对生长发育迟缓的识别和管理的积极方法需要重新评估。